News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kakkar Rahul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/01/2021 |
4
| Kakkar Rahul (CEO) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Unknown transaction of 14,000 shares
@ $60, valued at
$840k
Unknown transaction of 702,515 shares
@ $60, valued at
$42.2M
Disposed/sold 348,741 options to buy
@ $18, valued at
$6.3M
Disposed/sold 221,367 options to buy
@ $17.75, valued at
$3.9M
|
|
| 07/21/2020 |
4
| Kakkar Rahul (CEO) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 21,133 shares
@ $0
Bought 14,000 shares
@ $18, valued at
$252k
Granted 27,181 options to buy
@ $18, valued at
$489.3k
Granted 221,067 options to buy
@ $18, valued at
$4M
Granted 100,493 options to buy
@ $18, valued at
$1.8M
Converted 107,768 preferred shares
@ $0 |
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|